Curated News
By: NewsRamp Editorial Staff
May 30, 2025
Study Links Autism to Higher Risk of Parkinson's Disease
TLDR
- Link between autism spectrum disorder and Parkinson’s disease discovered, potential for companies like Clene Inc. (NASDAQ: CLNN) to capitalize.
- Karolinska Institutet study establishes biological link between ASD and PD, suggesting shared underlying mechanisms.
- Research on ASD-PD link may lead to better understanding, treatment, and prevention of Parkinson’s disease, improving healthcare outcomes.
- Fascinating study reveals connection between ASD and PD, opening new avenues for medical research and potential breakthroughs.
Impact - Why it Matters
This news sheds light on a potential connection between ASD and PD, impacting individuals with autism and raising awareness about the risks of developing Parkinson's disease. Companies like Clene Inc. may use this research to bring new treatments to market, potentially improving the lives of those affected by these conditions.
Summary
A recent study by Karolinska Institutet in Sweden has linked autism spectrum disorder to an increased risk of Parkinson's disease, suggesting shared biological mechanisms. Clene Inc. (NASDAQ: CLNN) stands to benefit from emerging data on Parkinson's development. The study was published in JAMA Neurology.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Study Links Autism to Higher Risk of Parkinson's Disease
